Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

LC–MS bioanalysis of intact proteins and peptides

Kang L, Weng N, Jian W. Biomedical Chromatography 2020

Document identifier
CEI-BR-056
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Kang L, Weng N, Jian W
Title
LC–MS bioanalysis of intact proteins and peptides
Source
Biomedical Chromatography
Year
2020
Volume, issue, pages
34(1):e4633
Digital object identifier
10.1002/bmc.4633
PubMed identifier
31215680
Record type
Journal article
Institute identifier
CEI-BR-056

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

DocumentSeries
Standard CEI-MS-02: Confirmation of peptide identity by liquid chromatography–tandem mass…Methodological standard
Standard CEI-MS-08: Related-substances profiling and the detection of isobaric impuritiesMethodological standard
2 citing documents.

§1.3Subject tags

lc-ms peptide method

Compound Evidence Institute · CEI-BR-056 · https://compoundevidence.com/bibliography/kang2020/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.